针对各种KRAS突变物寻找治疗药物的计算技术的演变:一篇综述文章
Ayesha Mehmood1, Mohammed Ageeli Hakami2, Hanan A Ogaly3
1Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan, Pakistan.
Cancer chemotherapy and pharmacology
|April 8, 2025
概括
通过识别新的KRAS抑制剂,计算方法正在推进癌症治疗. 研究人员正在探索全囊,并使用机器学习开发新的抗KRAS药物,基于最近的FDA批准.
科学领域:
- 在瘤学瘤学.
- 计算化学的计算化学
- 药物发现 药物发现 药物发现
背景情况:
- KRAS突变在癌症发育中至关重要,驱动恶性瘤,血管新生和转移.
- 针对癌症治疗的KRAS一直是具有挑战性的,因为在设计竞争性抑制剂方面存在困难.
- 最近的进展包括FDA批准了第一个KRAS G12C共价抑制剂AMG 510.
研究的目的:
- 审查用于发现针对各种KRAS突变的新型化合物的计算方法.
- 为突出KRAS向治疗的计算机辅助药物设计的突破.
- 确定有前途的候选药物和适合的结合部位,用于未来的抗KRAS药物开发.
主要方法:
- 虚拟选是一个虚拟的选.
- 分子动力学 (MD) 模拟
- 分子对接,包括共价对接研究.
- 机器学习和深度学习的方法.
主要成果:
- 计算调查揭示了适合全抑制剂设计的临时口袋.
- 鉴定出阿法替尼和奎尔塞丁是计算衍生的成功.
- 开关I/II口袋被证实是药物设计的可行地点.
结论:
- 计算方法,特别是虚拟查和MD模拟,对于识别KRAS抑制剂候选者至关重要.
- 新兴的机器学习和深度学习方法为抗KRAS药物开发提供了新的途径.
- 需要进一步的研究来验证计算识别的抑制剂,并探索全抑制策略.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.5K
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
7.3K
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
